We are live on ! Find out more
Aberdeen Group

Aberdeen Group Portfolio holdings

AUM $71.2B
1-Year Est. Return 41.74%
This Fund
S&P 500
This Quarter Est. Return
-3.02%
1 Year Est. Return
+41.74%
3 Year Est. Return
+120.47%
5 Year Est. Return
+149.18%
10 Year Est. Return
AUM
$61.9B
AUM Growth
-$2.65B
Cap. Flow
+$879M
Cap. Flow %
1.42%
Top 10 Hldgs %
36.04%
Holding
975
New
39
Increased
486
Reduced
379
Closed
44

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$130M
2
MSFT icon
Microsoft
MSFT
+$78.5M
3
NVDA icon
NVIDIA
NVDA
+$71M
4
AMZN icon
Amazon
AMZN
+$61.8M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$61.7M

Sector Composition

Rank Sector Weight
1 Technology 31.22%
2 Healthcare 13.42%
3 Consumer Discretionary 10.95%
4 Communication Services 10.94%
5 Financials 10.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HEPS
926
D-Market Electronic Services & Trading
HEPS
$1.05B
$194K ﹤0.01%
74,212
-2,887
-4% -$7.88K
SOFI icon
927
SoFi Technologies
SOFI
$21B
$193K ﹤0.01%
12,170
+3,442
+39% +$72.6K
PSKY
928
Paramount Skydance Corp
PSKY
$8.91B
$146K ﹤0.01%
16,211
-1,272
-7% -$13.9K
FINV
929
FinVolution Group
FINV
$1.15B
$106K ﹤0.01%
22,026
-689
-3% -$3.65K
NIO icon
930
NIO
NIO
$12.2B
$60.4K ﹤0.01%
10,020
-2,817
-22% -$14.2K
SNAP icon
931
Snap
SNAP
$7.89B
$52.1K ﹤0.01%
+11,328
New +$66.7K
ABEO icon
932
Abeona Therapeutics
ABEO
$366M
-616,413
Closed -$3.25M
ACLX
933
DELISTED
Arcellx
ACLX
-60,364
Closed -$3.94M
ACMR icon
934
ACM Research
ACMR
$5.42B
-8,386
Closed -$331K
ADMA icon
935
ADMA Biologics
ADMA
$1.96B
-963,949
Closed -$17.6M
AIV
936
Aimco
AIV
$387M
-53,135
Closed -$316K
ALEX
937
DELISTED
Alexander & Baldwin
ALEX
-26,207
Closed -$541K
AQST icon
938
Aquestive Therapeutics
AQST
$463M
-809,203
Closed -$5.23M
ARCC icon
939
Ares Capital
ARCC
$13.5B
-130,322
Closed -$2.64M
BDN
940
Brandywine Realty Trust
BDN
$524M
-55,420
Closed -$162K
BEKE icon
941
KE Holdings
BEKE
$18.7B
-270,085
Closed -$4.26M
BNTX icon
942
BioNTech
BNTX
$22.9B
-44,060
Closed -$4.19M
BXSL icon
943
Blackstone Secured Lending
BXSL
$5.37B
-203,521
Closed -$5.36M
CIB icon
944
Grupo Cibest SA
CIB
$22B
-5,027
Closed -$320K
CORT icon
945
Corcept Therapeutics
CORT
$12.4B
-245,093
Closed -$8.53M
CSIQ icon
946
Canadian Solar
CSIQ
$1.02B
-61,597
Closed -$1.46M
CYH icon
947
Community Health Systems
CYH
$393M
-1,772,139
Closed -$5.53M
CYBR
948
DELISTED
CyberArk
CYBR
-4,744
Closed -$2.12M
DBRG icon
949
DigitalBridge
DBRG
$2.93B
-180,352
Closed -$2.77M
ELME
950
Elme Communities
ELME
$143M
-31,549
Closed -$549K

Similar funds

Aberdeen Group's Q1 2026 Portfolio in Review

As of Q1 2026, Aberdeen Group held 975 positions worth $61.9B, down 4.1% from $64.6B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Aberdeen Group's Q1 2026 filing shows 39 new, 486 increased, 379 reduced and 44 closed positions. Its largest new stake was Veradermics Inc: 1,054,660 shares worth $66.6M. The largest sale was Spotify, an estimated $107M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 33% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Aberdeen Group's largest Q1 2026 buy was Veradermics Inc: 1,054,660 shares worth $66.6M.
  • Aberdeen Group added most to Apple in Q1 2026, an estimated $130M increase.
  • Aberdeen Group's biggest Q1 2026 reduction was Spotify, cutting an estimated $107M.
  • Aberdeen Group fully exited Vertex in Q1 2026, selling an estimated $24.4M.
  • Aberdeen Group's ten largest holdings make up 36% of its $61.9B portfolio in Q1 2026.
  • Aberdeen Group opened 39 new positions and closed 44 in Q1 2026.
  • Aberdeen Group's portfolio value fell 4.1% quarter-over-quarter to $61.9B.

Based on Aberdeen Group's 13F filing for Q1 2026, filed 29 Apr 2026.